Select for export Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1301960 PubMed 38699449 Copy citation Copy BibTeX Frontiers in Psychiatry 2024-04-17 Julia R. Wang, Samuel J. Mendez Araque, Gina Micciche, Andrew McMillan, Emily Coughlin, Rosalie Mattiola OpenAlex Published psilocybin AnxietyEnd-of-Life DistressChronic Pain Observational Study More
Select for export Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14728214.2024.2342951 PubMed 38606899 Copy citation Copy BibTeX Unknown journal 2024-04-17 Köhne S, Hillemacher T, Glahn A, Bach P. Europe PMC Published psilocybin AddictionClinical TrialReview Article Clinical Trial More
Select for export Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-024-58318-x PubMed 38632313 Copy citation Copy BibTeX Scientific Reports 2024-04-16 Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00048674241240597 PubMed 38628079 Copy citation Copy BibTeX Unknown journal 2024-04-15 Hatfield SP, Thornton NL, Greenstien K, Glozier N. Europe PMC Published psilocybin Review Article Review Article More
Select for export A dual-receptor model of serotonergic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.04.12.589282 Copy citation Copy BibTeX bioRxiv 2024-04-14 Juliani A, Chelu V, Graesser L, Safron A. bioRxiv PREPRINT (not peer reviewed) psilocybin AnxietyMechanism of ActionReceptor Pharmacology Other More
Select for export Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamapsychiatry.2024.0420 PubMed 38598200 Copy citation Copy BibTeX JAMA Psychiatry 2024-04-09 Eiko I. Fried, Ioana A. Cristea, Florian Naudet OpenAlex Published psilocybin DepressionSafety Other More
Select for export Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.isci.2024.109686 PubMed 38660396 Copy citation Copy BibTeX iScience 2024-04-08 Ram Harari, Ipsita Chatterjee, Dmitriy Getselter, Evan Elliott OpenAlex Published psilocybinpsilocin DepressionAnxietyNeuroplasticity Animal Study More
Select for export Mechanisms of therapeutic change after psychedelic treatment in OCD No abstract availability was recorded for this entry. Details DOI 10.1016/j.psychres.2024.115907 PubMed 38615521 Copy citation Copy BibTeX Psychiatry Research 2024-04-06 Gayle Maloney, Terence H. W. Ching, Stephen A. Kichuk, Christopher Pittenger, Benjamin Kelmendi OpenAlex Published psilocybin OCDMechanism of ActionReceptor Pharmacology Qualitative Study More
Select for export A double-edged sword: Insights from practitioners on the short and long-term negative effects of psilocybin-assisted psychological interventions Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2024.00337 Copy citation Copy BibTeX Journal of Psychedelic Studies 2024-04-01 M. Nordin, Jón Ingi Hlynsson, Jakob Håkansson Eklund, Per Carlbring OpenAlex Published psilocybin Safety Other More
Select for export Current situation regarding psychedelics and magic mushroom in Korea Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2024.1695 Copy citation Copy BibTeX European Psychiatry 2024-03-31 J. S. Seo OpenAlex Published psilocybinpsilocin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Microdosing psychedelics in the treatment of ADHD and comorbid disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2024.44 Copy citation Copy BibTeX European Psychiatry 2024-03-31 Kim P. C. Kuypers OpenAlex Published psilocybin DepressionChronic PainNeuroplasticity Clinical Trial More
Select for export Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamanetworkopen.2024.5960 PubMed 38598236 Copy citation Copy BibTeX Unknown journal 2024-03-31 Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J. Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/adb.13386 PubMed 38600715 Copy citation Copy BibTeX Unknown journal 2024-03-30 Tap SC. Europe PMC Published psilocybin AddictionNeuroplasticityPharmacology Review Article More
Select for export MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.04.4.1 Copy citation Copy BibTeX Psychiatric News 2024-03-25 Terri D’Arrigo OpenAlex Published psilocybin AnxietyPharmacologyClinical Trial Clinical Trial More
Select for export Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241237870 PubMed 38520045 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-03-21 David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Psychedelic drugs and the law: What’s next? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1146/knowable-031424-2 Copy citation Copy BibTeX Knowable Magazine 2024-03-13 Ben Seal OpenAlex Published psilocybinpsilocin DepressionAnxietyPTSD Systematic Review More
Select for export The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0300501 PubMed 38483940 Copy citation Copy BibTeX PLoS ONE 2024-03-13 Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Theodore L. Wagener OpenAlex Published psilocybin DepressionMystical ExperienceClinical Trial Randomized Controlled Trial More
Select for export Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11469-024-01253-9 Copy citation Copy BibTeX International Journal of Mental Health and Addiction 2024-03-06 Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/mjt.0000000000001727 PubMed 38518266 Copy citation Copy BibTeX American Journal of Therapeutics 2024-02-29 Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans OpenAlex Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/mjt.0000000000001724 PubMed 38518269 Copy citation Copy BibTeX American Journal of Therapeutics 2024-02-29 Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans OpenAlex Published psilocybin DepressionAnxietyAddiction Clinical Trial More
